[Tisagenlecleucel (diffuse large B-cell lymphoma) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V (expiry of the decision)]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003693
German
Original Title:
Tisagenlecleucel (diffuses großzelliges B-Zell-Lymphom)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g20-05.html
Year Published:
2020
URL for published report:
https://www.iqwig.de/download/G20-05_Tisagenlecleucel_Bewertung-35a-Absatz-1-Satz-11-SGB-V_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Lymphoma, Large B-Cell, Diffuse
- Receptors, Chimeric Antigen
- Immunotherapy, Adoptive
- Receptors, Antigen, T-Cell
- Antineoplastic Agents, Immunological
Keywords
- Tisagenlecleucel
- Lymphoma - Large B-Cell - Diffuse
- Health Care Costs
- Epidemiology
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.